|Length of treatment
Nov 13, 2000
Are there any data that suggest longer treatment has a greater likelihood of cure. Specifically, a friend's liver specialist has suggested he stay on his interferon and ribatron therapy longer than the recommended 6 months, since he is co-infected with HIV. He has genotype "2" virus. His HEP C viral load has been undetectable for the past few months (as is his HIV viral load), and liver enzymes are within normal range. Is there any reason to extend the therapy. He is having unpleasant side effects, i.e., severe lethargy, body aches, depression, and irritability, and would prefer not to stay on treatment longer than necessary. However, if there were data suggesting prognosis would be improved he would consider longer treatment. Your advice is greatly appreciated.
Response from Dr. Dieterich
Generally speaking, longer is better. Most of us treat HIV+ patients with genotype 2 and 3 for 12 months, because we assume that there is a higher relapse rate. Psychologically I feel it is better to go longer and be reasonably certain of a cure than stop and have to go back on therapy for the second time certainly for a year. DTD
what is hep c genotype 1a
HIV protection from Hep Vaccine
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.